Evidence map›Paper›PMID 39690303›Full record

ArticleEye (London, England)2025

Benchmarking the performance of large language models in uveitis: a comparative analysis of ChatGPT-3.5, ChatGPT-4.0, Google Gemini, and Anthropic Claude3.

Fang-Fang Zhao, Han-Jie He, Jia-Jian Liang, Jingyun Cen, Yun Wang, Hongjie Lin, Feifei Chen, Tai-Ping Li, Jian-Feng Yang, Lan Chen and 1 more

Abstract readComparative Study
In one paragraph

Article in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Patient and physician perspectives on large language model generated responses about brain aneurysm.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fang-Fang Zhao *Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong, China.
Han-Jie He *Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong, China.
Jia-Jian Liang *Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong, China.
Jingyun CenShaoguan University Medical college, Shaoguan, China.
Yun WangJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong, China.
Hongjie LinJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong, China.
Feifei ChenJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong, China.
Tai-Ping LiJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong, China.
Jian-Feng YangJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong, China.
Lan ChenJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong, China.
Ling-Ping CenGuangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, School of Medical Technology, Guangdong Medical University, Zhanjiang, China. cenlp@hotmail.com.ORCID http://orcid.org/0000-0003-3876-0606

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectiveThis study aimed to evaluate the accuracy, comprehensiveness, and readability of responses generated by various Large Language Models (LLMs) (ChatGPT-3.5, Gemini, Claude 3, and GPT-4.0) in the clinical context of uveitis, utilizing a meticulous grading methodology.

methodsTwenty-seven clinical uveitis questions were presented individually to four Large Language Models (LLMs): ChatGPT (versions GPT-3.5 and GPT-4.0), Google Gemini, and Claude. Three experienced uveitis specialists independently assessed the responses for accuracy using a three-point scale across three rounds with a 48-hour wash-out interval. The final accuracy rating for each LLM response ('Excellent', 'Marginal', or 'Deficient') was determined through a majority consensus approach. Comprehensiveness was evaluated using a three-point scale for responses rated 'Excellent' in the final accuracy assessment. Readability was determined using the Flesch-Kincaid Grade Level formula. Statistical analyses were conducted to discern significant differences among LLMs, employing a significance threshold of p < 0.05.

resultsClaude 3 and ChatGPT 4 demonstrated significantly higher accuracy compared to Gemini (p < 0.001). Claude 3 also showed the highest proportion of 'Excellent' ratings (96.3%), followed by ChatGPT 4 (88.9%). ChatGPT 3.5, Claude 3, and ChatGPT 4 had no responses rated as 'Deficient', unlike Gemini (14.8%) (p = 0.014). ChatGPT 4 exhibited greater comprehensiveness compared to Gemini (p = 0.008), and Claude 3 showed higher comprehensiveness compared to Gemini (p = 0.042). Gemini showed significantly better readability compared to ChatGPT 3.5, Claude 3, and ChatGPT 4 (p < 0.001). Gemini also had fewer words, letter characters, and sentences compared to ChatGPT 3.5 and Claude 3.

conclusionsOur study highlights the outstanding performance of Claude 3 and ChatGPT 4 in providing precise and thorough information regarding uveitis, surpassing Gemini. ChatGPT 4 and Claude 3 emerge as pivotal tools in improving patient understanding and involvement in their uveitis healthcare journey.

Indexed as

BenchmarkingUveitisComprehensionGenerative Artificial IntelligenceHumansLarge Language Models

Identifiers

PMID39690303
PMCPMC11978972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.